Compare PLSE & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLSE | NVST |
|---|---|---|
| Founded | 2014 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 4.0B |
| IPO Year | 2015 | 2019 |
| Metric | PLSE | NVST |
|---|---|---|
| Price | $45.10 | $22.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 15 |
| Target Price | ★ $67.67 | $28.92 |
| AVG Volume (30 Days) | 365.7K | ★ 2.9M |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 104.31 |
| EPS | N/A | ★ 3.65 |
| Revenue | N/A | ★ $2,566,500,000.00 |
| Revenue This Year | $406.29 | $5.58 |
| Revenue Next Year | $157.24 | $3.20 |
| P/E Ratio | ★ N/A | $6.38 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.95 | $19.67 |
| 52 Week High | $58.94 | $30.42 |
| Indicator | PLSE | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 39.93 | 40.04 |
| Support Level | $43.32 | $22.72 |
| Resistance Level | $57.14 | $27.68 |
| Average True Range (ATR) | 4.43 | 1.10 |
| MACD | -1.23 | -0.25 |
| Stochastic Oscillator | 13.61 | 2.29 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.